Sansevieria trifasciata (Dracaena trifasciata): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Sansevieria trifasciata help heal wounds?

Sansevieria trifasciata contains bioactive compounds including saponins, tannins, flavonoids, and dracaenins that contribute to its wound-healing properties. These compounds demonstrate antimicrobial activity against pathogens and provide anti-inflammatory effects when applied topically. The tannins act as astringents to help contract wound tissue, while saponins may support cellular regeneration. Evidence Level: C (preliminary research and traditional use).

Does snake plant interact with any medications?

There are no well-documented drug interactions for Sansevieria trifasciata in clinical literature, as it is primarily used topically rather than internally. However, the plant contains saponins that can affect nutrient absorption and may theoretically interact with medications metabolized by the liver. Due to limited research, individuals taking prescription medications should consult a healthcare provider before using Sansevieria preparations. Internal use is not recommended due to toxicity concerns.

What is the recommended dosage for Sansevieria trifasciata?

Sansevieria trifasciata is used exclusively as a topical preparation in traditional medicine. The fresh juice or leaf gel is applied directly to wounds, skin infections, or used as ear drops for ear conditions. There is no established safe internal dosage due to the presence of toxic saponins that cause gastrointestinal distress. Traditional practitioners in West Africa typically apply the juice two to three times daily to affected areas. Evidence Level: Traditional use only.

Is Sansevieria safe to use during pregnancy?

Sansevieria trifasciata is considered unsafe during pregnancy and should be avoided. The plant contains saponins and other compounds that can cause gastrointestinal toxicity when ingested, and these substances may potentially cross the placental barrier. Topical application is also not recommended during pregnancy due to insufficient safety data. Pregnant women, nursing mothers, and children should not use Sansevieria preparations internally or externally without medical supervision. Evidence Level: C.

What are the traditional medicinal uses of snake plant?

Sansevieria trifasciata, commonly known as snake plant, has been used in traditional African and Asian medicine for centuries. In West African folk medicine, it treats ear conditions and promotes wound healing. Nigerian and Kenyan traditional healers use it for skin infections and topical inflammation. Modern research from NASA has also demonstrated its air-purifying properties, removing toxins like formaldehyde from indoor environments. Evidence Level: C (preliminary studies supporting traditional use).

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Sansevieria trifasciata (also known as Dracaena trifasciata) is an ornamental succulent used in traditional medicine for its antioxidant, anti-inflammatory, and regenerative properties [PMID:40943543].

Background

Sansevieria trifasciata is a monocotyledonous succulent plant in the Asparagaceae (or Dracaenaceae/Agavaceae) family, distributed in tropical and subtropical dry climate regions [PMID:38425137, PMID:33537442, PMID:30731820]. It is widely used as an indoor and outdoor ornamental plant and as a source of fiber [PMID:35596065, PMID:33537442].

Traditional uses

The plant has been widely used in traditional medicine in Mexico, other tropical regions, and the Bundelkhand region of India for its therapeutic potential [PMID:40943543, PMID:40207546]. It has also been used for wound healing [PMID:37675132].

Active compounds

Phytochemical analysis has identified flavonoids, terpenes, phenolic acids [PMID:40943543], saponins, phenols, tannins, glycosides, carbohydrates, and terpenoids [PMID:40207546]. Specific identified compounds include a derivative pyridone alkaloid (5-methyl-11-(2-oxopyridin-1(2H)-yl)undecaneperoxoicacid) [PMID:37630348], pregnane glycosides [PMID:8983214], steroidal saponins (trifasciatosides A-J) [PMID:27581639], and various metabolites such as Methyl pyrophaeophorbide A, Oliveramine, and Methyl gallate [PMID:35889232].

Mechanism of action

In silico studies suggest that certain compounds may inhibit androgen receptors [PMID:35889232] and co-inhibit hexokinase 2 (HK2) and glutaminase 1 (GLS1) associated with metabolic reprogramming in rheumatoid arthritis [PMID:36013327]. An isolated pyridone alkaloid interacts with the active site of β-ketoacyl-ACP synthase from E. coli and TyrRS from S. aureus [PMID:37630348].

Clinical evidence

Evidence DBacterial Infections

Extracts and isolated pyridone alkaloids demonstrate antibacterial activity against Escherichia coli and Streptococcus aureus [PMID:37630348, PMID:32127997, PMID:39687956].

Evidence DGastric Ulcers

Leaf extract pre-treatment in Wistar rats showed improvement against indomethacin-induced ulceration, curtailing the reduction in gastric volume [PMID:28512605].

Evidence DColorectal Cancer

Semi-purified methanolic extracts and ethanolic leaf extracts exhibit antiproliferative and cytotoxic potential against HCT116 human colorectal carcinoma cell lines [PMID:40308790, PMID:39687956].

Evidence CKidney Disease

A review suggests the plant may offer nephroprotective effects due to its high content of hydroxylated aromatic compounds [PMID:40943543].

Evidence DWound Healing

Hydrogel formulations of leaf extract (20% and 25% w/w) showed significant activity in an incision wound model in mice [PMID:37675132].

Safety & adverse effects

In Wistar rats, oral administration of leaf extract up to 18,000 mg/kg BW did not cause negative behavioral changes or mortality [PMID:28512605]. However, the plant has been reported as a cause of allergic rhinitis [PMID:33978588].

Evidence summary

The current evidence is primarily based on in vitro assays, in silico modeling, and animal models (D), with limited review-level data (C). No human clinical trials (B) or meta-analyses (A) were provided.

PubMed sources

1.PMID: 38425137 (2024) — A method of genetic transformation and gene editing of succulents without tissue culture. · Plant biotechnology journal
2.PMID: 40943543 (2025) — Nephroprotective Effect of Sansevieria trifasciata. · International journal of molecular sciences
3.PMID: 33134618 (2020) — Preliminary study on Cd accumulation characteristics in Sansevieria trifasciata Prain. · Plant diversity
4.PMID: 35596065 (2022) — Indirect organogenesis for high frequency shoot regeneration of two cultivars of Sansevieria trifasciata Prain differing in fiber production. · Scientific reports
5.PMID: 37630348 (2023) — Antibacterial Potency of an Active Compound from Sansevieria trifasciata Prain: An Integrated In Vitro and In Silico Study. · Molecules (Basel, Switzerland)

Sansevieria trifasciata

Sources & Citations

Calculate a safe dose of Sansevieria trifasciata